2024. CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma. Biomolecules and Biomedicine. (Jul. 2024). DOI:https://doi.org/10.17305/bb.2024.10397.